Abstract |
Signaling pathways for caspase-2-mediated apoptosis are poorly defined. This is partially due to a lack of a reproducible stimulus to trigger caspase-2 activation. We present the oligonucleotide Dz13, a DNA enzyme that cleaves c-Jun mRNA and is capable of inhibiting various model tumors in mice, which potently induces caspase-2 resulting in apoptosis in a panel of tumor cell lines. Dz13-mediated cell death occurred even in the absence of known caspase-2 molecular partners in p53-induced protein with a death domain, RIP-associated Ich-1/CED homologous protein with death domain, or DNA-dependent protein kinase catalytic subunit, or other caspases in cell lines of breast cancer, prostate cancer, osteosarcoma, and liposarcoma. z-VDVAD-fmk, caspase-2(-/-) mouse embryonic fibroblasts and siRNA silencing of caspase-2 in tumor cells abrogated Dz13-mediated cell death. In an orthotopic tumor model, expression of caspase-2 increased as the tumor metastasized and caspase-2 expression was sporadic in patient tumor specimens. These findings provide hope that Dz13, and other agents that evoke activation of caspase-2, may be therapeutic clinically.
|
Authors | Crispin R Dass, Stuart J Galloway, Peter F M Choong |
Journal | Oligonucleotides
(Oligonucleotides)
Vol. 20
Issue 3
Pg. 137-46
(Jun 2010)
ISSN: 1557-8526 [Electronic] United States |
PMID | 20180631
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Chemical References |
- DNA Primers
- DNA, Catalytic
- Dz13 DNAzyme
- Caspase 2
|
Topics |
- Animals
- Base Sequence
- Caspase 2
(metabolism)
- Catalytic Domain
- Cell Line, Tumor
- DNA Primers
- DNA, Catalytic
(chemistry, metabolism)
- Enzyme Activation
- Female
- Humans
- Immunohistochemistry
- In Situ Nick-End Labeling
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Neoplasms
(enzymology, pathology)
- Reverse Transcriptase Polymerase Chain Reaction
|